[1] LEVER R,PAGE C P.Novel drug development opportunities for heparin[J].Nat Rev Drug Discov,2002,1(2): 140-148.
[2] GOMES O M,GOMES E S.Dipyridamole and low doses of heparin as a new successful physiopathologic and therapeutic approach in 2 cases of disseminated intravascular coagulation[J].Heart Surg Forum,2010,13(1): E49-E51.
[3] GRAY E,MULLOY B,BARROWCLIFFE T W.Heparin and low-molecular-weight heparin[J].Thromb Haemost,2008,99(5): 807-818.
[4] MU E,DING R,AN X,et al.Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and TGF-beta/Smad signaling pathway[J].Thromb Res,2012,129(4): 479-485.
[5] YOUNG E.The anti-inflammatory effects of heparin and related compounds[J].Thromb Res,2008,122(6): 743-752.
[6] WANG M,HE J,MEI B,et al.Therapeutic effects and anti-inflammatory mechanisms of heparin on acute lung injury in rabbits[J].Acad Emerg Med,2008,15(7): 656-663.
[7] LUO J,CAO J,JIANG X,et al.Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in mice[J].Biomed Pharmacother,2010,64(7): 441-445.
[8] LAKSHMI T S,SHANMUGASUNDARAM N,SHANMUGANATHAN S,et al.Efficacy of desulfated heparin mitigating inflammation in rat burn wound model[J].J Biomed Mater Res B Appl Biomater,2011,97(2): 215-223.
[9] PATEL B,GUPTA N,AHSAN F.Low-molecular-weight heparin(LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma[J].J Aerosol Med Pulm Drug Deliv,2014,27(1): 12-20.
[10] ZHAO D,DING R,MAO Y,et al.Heparin rescues sepsis-associated acute lung injury and lethality through the suppression of inflammatory responses[J].Inflammation,2012,35(6): 1825-1832.
[11] CASU B,ORESTE P,TORRI G,et al.The structure of heparin oligosaccharide fragments with high anti-(factor Xa)activity containing the minimal antithrombin III-binding sequence.Chemical and 13C nuclear-magnetic-resonance studies[J].Biochem J,1981,197(3): 599-609.
[12] 郭莹,李腾.肝素雾化吸入对慢性阻塞性肺疾病大鼠模型气道炎症的抑制作用[J].中国现代医学杂志,2011(5): 572-574.
[13] HOCHART H,JENLINS P V,SMITH O P,et al.Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes[J].Br J Haematol,2006,133(1): 62-67.
[14] HANDEL T M,JOHNSON Z,CROWN S E,et al.Regulation of protein function by glycosaminoglycans-as exemplified by chemokines[J].Annu Rev Biochem,2005,74: 385-410.
[15] CHEN J L,FAN J,CHEN M X,et al.Effect of non-anticoagulant N-desulfated heparin on basic fibroblast growth factor expression,angiogenesis,and metastasis of gastric carcinoma in vitro and in vivo[J].Gastroenterol Res Pract,2012,2012: 752940.
[16] LEE J H,LEE H,JOUNG Y K,et al.The use of low molecular weight heparin-pluronic nanogels to impede liver fibrosis by inhibition the TGF-beta/Smad signaling pathway[J].Biomaterials,2011,32(5): 1438-1445.
[17] TYRELL D J,KILFEATHER S,PAGE C P.Therapeutic uses of heparin beyond its traditional role as an anticoagulant[J].Trends Pharmacol Sci,1995,16(6): 198-204.
[18] 李志鹏,张玉平,赵自刚,等.白细胞在全身炎症反应综合征发生机制中的作用[J].中国医疗前沿,2011,6(12): 9,29.
[19] LEVER R,SMAILBEGOVIC A,PAGE C P.Locally available heparin modulates inflammatory cell recruitment in a manner independent of anticoagulant activity[J].Eur J Pharmacol,2010,630(1-3): 137-144.
[20] LORANT D E,TOPHAM M K,WHATLEY R E,et al.Inflammatory roles of P-selectin[J].J Clin Invest,1993,92(2): 559-570.
[21] DIAMOND M S,ALON R,PARKOS C A,et al.Heparin is an adhesive ligand for the leukocyte integrin Mac-1(CD11b/CD1)[J].J Cell Biol,1995,130(6): 1473-1482.
[22] LI X,ZHENG Z,LI X,et al.Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-kappaB activation on endothelial cell[J].Cytokine,2012,60(1): 114-121.
[23] PETTIGREW L C,KINDY M S,SCHEFF S,et al.Focal cerebral ischemia in the TNFalpha-transgenic rat[J].J Neuroinflammation,2008,5: 47.
[24] SUN M,DAWOOD F,WEN W H,et al.Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction[J].Circulation,2004,110(20): 3221-3228.
[25] PEVNI D,FROLKIS I,SHAPIRA I,et al.Heparin added to cardioplegic solution inhibits tumor necrosis factor-alpha production and attenuates myocardial ischemic-reperfusion injury[J].Chest,2005,128(3): 1805-1811.
[26] SCHULTZ D R,HARRINGTON W J.Apoptosis: programmed cell death at a molecular level[J].Semin Arthritis Rheum,2003,32(6): 345-369.
[27] BAGEL'OVA J,ANTALIK M,BONA M.Studies on cytochrome c-heparin interactions by differential scanning calorimetry[J].Biochem J,1994,297(Pt 1): 99-101.
[28] COLLINO M,PINI A,MASTROIANNI R,et al.The non-anticoagulant heparin-like K5 polysaccharide derivative K5-N,OSepi attenuates myocardial ischaemia/reperfusion injury[J].J Cell Mol Med,2012,16(9): 2196-2207.
[29] WANG L,BROWN J R,VARKI A,et al.Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L-and P-selectins[J].J Clin Invest,2002,110: 127-136. |
